5'-O-(4,4'-Dimethoxytrityl)-2,2'-anhydro-D-uridine manufacturers
|
| | 5'-O-(4,4'-Dimethoxytrityl)-2,2'-anhydro-D-uridine Basic information |
| Product Name: | 5'-O-(4,4'-Dimethoxytrityl)-2,2'-anhydro-D-uridine | | Synonyms: | 5'-O-(4,4'-Dimethoxytrityl)-2,2'-anhydro-D-uridine;2,2'-Anhydro-5'-O-DMT-uridine;6H-Furo[2',3':4,5]oxazolo[3,2-a]pyrimidin-6-one, 2-[[bis(4-methoxyphenyl)phenylmethoxy]methyl]-2,3,3a,9a-tetrahydro-3-hydroxy-, (2R,3R,3aS,9aR)-;2,2'-anhydro-5'-O-(4,4'-dimethoxytrityl)uridine;5’-O-(4,4’-Dimethoxytrityl)-2,2’-anhydro-D-uridine;5'-Protected 2,2'-anhydrouridine;5 ' - 0 - (4,4'-Dimethoxytri- tyl) - 2, 2'-an hydro- D-uridine;5'-Protected 2,2'-anhydrouridine | | CAS: | 173170-12-2 | | MF: | C30H28N2O7 | | MW: | 528.55 | | EINECS: | | | Product Categories: | | | Mol File: | 173170-12-2.mol |  |
| | 5'-O-(4,4'-Dimethoxytrityl)-2,2'-anhydro-D-uridine Chemical Properties |
| | 5'-O-(4,4'-Dimethoxytrityl)-2,2'-anhydro-D-uridine Usage And Synthesis |
| Uses | 5'-Protected 2,2'-anhydrouridine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. | | References | [1] Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. DOI:10.2174/138161212801227005 |
| | 5'-O-(4,4'-Dimethoxytrityl)-2,2'-anhydro-D-uridine Preparation Products And Raw materials |
|